OTC and cancer: Down-regulation of ornithine transcarbamylase (OTC) (FC= −1.52 (95% CI −1.74 to −1.32), see Figure 8B) reduces the citrulline within mitochondria but increases ornithine in the cytoplasm, which helps in cancer initiation and progression [23].